EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudie

Comparative Analysis of Long-Term Outcomes of Submacular Hemorrhage in AMD: A Real-Life Study

Nicolas Chirpaz, Benjamin Matagrin, Lucas Gauthier, Sandra Elbany, Antonin Rocher, Thibaud Mathis, Inès Fenniri, Philippe Denis, Laurent Kodjikian, Carole Burillon, Corinne Dot

Ophthalmologica · 2025

DOI: 10.1159/000548392 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Ophthalmologica, 2025. Verfasst von Nicolas Chirpaz und 10 weiteren Autor:innen. Beteiligte Einrichtung: Edouard Herriot University Hospital, Ophthalmology Department, Hospices Civils de Lyon, Lyon, France, nicolas.chirpaz@chu-lyon.fr. Hauptthemen laut MEDLINE: Visual Acuity, Retinal Hemorrhage, Wet Macular Degeneration. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Submacular hemorrhage (SMH) is a severe complication of neovascular age-related macular degeneration (nAMD), often causing profound vision loss. The aim of this study was to assess the long-term outcomes of SMH patients managed with anti-VEGF monotherapy (MT) versus surgical displacement (SD) and to identify prognostic factors for visual acuity.

Methods

This multicenter retrospective study included patients with SMH secondary to nAMD treated in three hospitals in Lyon between 2018 and 2023. Patients were treated with MT or underwent pneumatic displacement (PD) or SD. The best-corrected visual acuity (BCVA) and clinical parameters were assessed at baseline (time of SMH onset), months 1, 3, 9, and 12.

Results

Sixty-six eyes were included: 33 received MT, 6 underwent PD, and 27 underwent SD. The baseline VA was strongly reduced (mean BCVA: 0.14). The VA improved to 0.21 at M1, 0.29 at M3, and 0.33 at M6 but was stabilized at 0.28 at M12. At M12, VA did not significantly differ between MT and SD groups (0.27 vs. 0.32, p = 0.624). However, multivariate analysis revealed a significantly greater VA gain in the SD group (p = 0.025), despite more severe baseline characteristics. SMH thickness was significantly associated with a poorer VA (p = 0.02).

Conclusion

SD may offer greater visual improvement in cases of large and thick SMH. Maximum SMH thickness appears to be a key prognostic factor. Treatment decisions should consider initial hemorrhage severity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Visual AcuityRetinal HemorrhageWet Macular DegenerationHumansRetrospective StudiesFemaleMaleIntravitreal InjectionsAngiogenesis InhibitorsAgedFollow-Up StudiesTomography, Optical CoherenceTime FactorsFluorescein AngiographyAged, 80 and overFundus OculiRanibizumabVascular Endothelial Growth Factor ATreatment OutcomeBevacizumab

Stichwörter der Autor:innen

Age-related macular degenerationMedical vs. surgical treatmentPrognostic factorsSubmacular hemorrhage

Substanzen

Angiogenesis InhibitorsRanibizumabVascular Endothelial Growth Factor ABevacizumab

Autor:innen und Institutionen

  • Edouard Herriot University Hospital, Ophthalmology Department, Hospices Civils de Lyon, Lyon, France, nicolas.chirpaz@chu-lyon.fr.
  • Claude Bernard Lyon 1 University, Lyon, France, nicolas.chirpaz@chu-lyon.fr.
  • Edouard Herriot University Hospital, Ophthalmology Department, Hospices Civils de Lyon, Lyon, France.
  • Croix Rousse University Hospital, Ophthalmology Department, Hospices Civils de Lyon, Lyon, France.
  • Laboratoire MATEIS, UMR-CNRS 5510, INSA, Université Lyon 1, Lyon, France.
  • Claude Bernard Lyon 1 University, Lyon, France.

Zitieren

APA

Chirpaz, N., Matagrin, B., Gauthier, L., Elbany, S., Rocher, A., Mathis, T., Fenniri, I., Denis, P., Kodjikian, L., Burillon, C., & Dot, C. (2025). Comparative Analysis of Long-Term Outcomes of Submacular Hemorrhage in AMD: A Real-Life Study. Ophthalmologica. https://doi.org/10.1159/000548392

Vancouver

Chirpaz N, Matagrin B, Gauthier L, Elbany S, Rocher A, Mathis T, et al. Comparative Analysis of Long-Term Outcomes of Submacular Hemorrhage in AMD: A Real-Life Study. Ophthalmologica. 2025. doi:10.1159/000548392

BibTeX
@article{Chirpaz2025,
  author = {Chirpaz, Nicolas and Matagrin, Benjamin and Gauthier, Lucas and Elbany, Sandra and Rocher, Antonin and Mathis, Thibaud and Fenniri, Inès and Denis, Philippe and Kodjikian, Laurent and Burillon, Carole and Dot, Corinne},
  title = {Comparative Analysis of Long-Term Outcomes of Submacular Hemorrhage in AMD: A Real-Life Study},
  journal = {Ophthalmologica},
  year = {2025},
  doi = {10.1159/000548392}
}
Kostenlos starten →